Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)
Crossref DOI link: https://doi.org/10.1038/bmt.2016.275
Published Online: 2016-11-28
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shah, N
Rauenzahn, S http://orcid.org/0000-0002-0293-9527
Veltri, L
Wen, S
Craig, M
Hamadani, M
Kanate, A S
Cumpston, A
Text and Data Mining valid from 2016-11-28
Version of Record valid from 2016-11-28
Article History
First Online: 28 November 2016
Competing interests
: The authors declare no conflict of interest.